{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:28:32Z","timestamp":1765279712001},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ejso.2010.04.012","type":"journal-article","created":{"date-parts":[[2010,5,22]],"date-time":"2010-05-22T09:01:55Z","timestamp":1274518915000},"page":"583-588","source":"Crossref","is-referenced-by-count":26,"title":["Perioperative morbidity and outcome of secondary cytoreduction for recurrent epithelial ovarian cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"L.","family":"Woelber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Eulenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Jaenicke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mahner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2010.04.012_bib1","article-title":"Cancer facts and figures","author":"American-Cancer-Society","year":"2009","journal-title":"Canc Stat"},{"issue":"59","key":"10.1016\/j.ejso.2010.04.012_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics","volume":"2009","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2010.04.012_bib3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer","volume":"95","author":"du Bois","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2010.04.012_bib4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/1097-0142(19921015)70:8<2129::AID-CNCR2820700820>3.0.CO;2-U","article-title":"Radical surgical procedure improves survival time in patients with recurrent ovarian cancer","volume":"70","author":"Janicke","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2010.04.012_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0301-2115(99)00067-6","article-title":"Surgical treatment of recurrent ovarian cancer: report of 21 cases and a review of the literature","volume":"86","author":"Cormio","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejso.2010.04.012_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2010.04.012_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejso.2004.08.016","article-title":"Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum","volume":"31","author":"Gronlund","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ygyno.2004.11.057","article-title":"The role of secondary cytoreductive surgery for recurrent ovarian cancer","volume":"97","author":"Gungor","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib10","first-page":"570","article-title":"Treatment of recurrent ovarian cancer","volume":"27","author":"Hacker","year":"2004","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.ejso.2010.04.012_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.cco.0000174166.06734.c7","article-title":"The role of surgery in ovarian cancer with special emphasis on cytoreductive surgery for recurrence","volume":"17","author":"Harter","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2004.09.018","article-title":"Critical evaluation of secondary cytoreduction in recurrent ovarian cancer","volume":"95","author":"Munkarah","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib13","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/gyno.2001.6404","article-title":"Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma","volume":"83","author":"Scarabelli","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1040-8428(01)00174-3","article-title":"Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial","volume":"41","author":"Selman","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejso.2010.04.012_bib15","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0029-7844(02)01977-4","article-title":"Secondary cytoreductive surgery for recurrent epithelial ovarian cancer","volume":"99","author":"Tay","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejso.2010.04.012_bib16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/cncr.20106","article-title":"Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?","volume":"100","author":"Zang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2010.04.012_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2008.12.015","article-title":"Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia","volume":"105","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejso.2010.04.012_bib18","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2010.04.012_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/gyno.2000.5992","article-title":"Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer","volume":"79","author":"Gadducci","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2010.04.012_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1447-0756.1998.tb00122.x","article-title":"Operative results after primary and secondary debulking-operations in advanced ovarian cancer (AOC)","volume":"24","author":"Lichtenegger","year":"1998","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.ejso.2010.04.012_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798310001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798310001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T00:51:17Z","timestamp":1544489477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798310001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0748798310001010"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2010.04.012","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}